Coronary Bypass Surgery Trial: Complete Arterial Revascularization and Conventional Coronary Artery Surgery
Complete Arterial Revascularization and Conventional Coronary Artery Surgery Study (CARACCASS)-European Multicenter Study
1 other identifier
interventional
2,000
7 countries
14
Brief Summary
This is a randomized, prospective European Multicenter Study comparing complete arterial revascularization of the coronary arteries using arterial graft material exclusively and "conventional" coronary artery bypass surgery using the left internal thoracic artery as graft to the left anterior descending artery (LAD) and vein grafts to other vessels to be bypassed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable coronary-artery-disease
Started Jan 1999
Longer than P75 for not_applicable coronary-artery-disease
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1999
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2005
CompletedFirst Submitted
Initial submission to the registry
April 20, 2006
CompletedFirst Posted
Study publicly available on registry
April 24, 2006
CompletedOctober 13, 2006
March 1, 2006
April 20, 2006
October 12, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
All cause mortality perioperatively, one year, five and ten years.
Secondary Outcomes (1)
Combined cardiac death, non-fatal myocardial infarction and repeat revascularisation at one, five and ten years.
Interventions
Eligibility Criteria
You may qualify if:
- Patient eligible for surgical myocardial revascularization
- Age 70 years or less
- Triple vessel coronary disease with significant coronary artery stenosis defined as a stenosis of at least 50% in luminal diameter
- Patients with stable angina pectoris (Canadian Cardiovascular Society 1, 2, 3, or 4) or unstable angina pectoris (Braunwald Classification 1b, 2b, 3b) or proven silent myocardial ischemia.
You may not qualify if:
- No informed consent
- Age \> 65 years
- Participation in another study with any investigational drug or coronary revascularization procedure
- When follow up over a period of five years is difficult or unlikely
- Concomitant non-cardiac disease likely to limit long-term prognosis (e.g. cancer)
- One or two vessel coronary disease and isolated left main stenosis
- Estimated left ventricular ejection fraction \< 25%
- Myocardial infarction within seven days
- Need for concomitant major cardiac or non-cardiac surgery (e.g. valve surgery, left ventricular aneurysm, aortic aneurysm, carotid artery desobliteration, etc.)
- Redo-cardiac surgery
- Presence of the combination of insulin dependent diabetes mellitus and chronic obstructive pulmonary disease requiring therapy
- Renal insufficiency requiring dialysis
- Presence of the combination of severe adiposity and insulin dependent diabetes mellitus
- Presence of the combination of severe adiposity and chronic obstructive pulmonary disease requiring therapy
- Severe hepatic disease
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (14)
Dept. of Surgery I, AKH Linz
Linz, 4020, Austria
Dept Cardiothoracic Surgery, Medical Univ. of Vienna
Vienna, A-1090, Austria
Clinic for Cardiovascular Surgery, IKEM
Prague, 14000, Czechia
Kardiochirurgie, Nemocnice Podlesi
Třinec, 73961, Czechia
Kerckhoff-Klinik
Bad Nauheim, Germany
Dept.of Cardiac Surg, Ruhr University
Bochum, 44789, Germany
Dept of Cardiothoracic and Vascular Surgery, J-W-Goethe University
Frankfurt, 60590, Germany
HKZ Rotenburg
Rothenburg An Der Fulda, 36199, Germany
Hjerteklinikken St. Elisabeth, Regionsykehuset Trondheim
Trondheim, 7018, Norway
Dept Cardiothoracic Surg, Univ. of Gdansk
Gdansk, 80211, Poland
Dept of Cardiovasc Surg, Hospital Clinico, University of Barcelona
Barcelona, 08036, Spain
Dept of Cardiac Surg, Hospital de Cruces
Bilbao, 48190, Spain
Dept. of Cardiovascular Surgery, University of Salamanca
Salamanca, Spain
Department of Cardiothoracic Surgery, University Hospital
Linköping, 58185, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Simon, MD
Dept. of Cardiothoracic Surgery, Medical Univ. of Vienna
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 20, 2006
First Posted
April 24, 2006
Study Start
January 1, 1999
Study Completion
January 1, 2005
Last Updated
October 13, 2006
Record last verified: 2006-03